Lv51
1380 积分 2024-02-13 加入
Approved Steroidal Drugs (2000–2025): A Medicinal Chemistry Perspective
1小时前
已完结
Discovery and Development of Lorlatinib: A Macrocyclic Inhibitor of EML4-ALK for the Treatment of NSCLC
19天前
已完结
Lorlatinib. ALK/ROS1 inhibitor, Treatment of non-small cell lung cancer
1个月前
已完结
Recent Advances in the Mitsunobu and Related Reactions: A Review from 2010 to 2024
3个月前
已完结
皖公网安备34019202002308
